fbpx
 

ENZYME BLOGAnalyzing the latest developments in regulatory, compliance, and quality

FDA Drives ‘Stake In Ground’ With Glossary For AI, Digital Health Terms

By Shawn M. Schmitt Communications Specialist, Enzyme The US Food and Drug Administration (FDA) has taken a critical step toward ensuring that makers of medical devices are all on the same page when it comes to defining terms related to artificial intelligence (AI) and digital health, says an ex-agency official. Posted online in late September,...